203 Drugs Flashcards
(122 cards)
Fludrocortisol
Used for mineralocorticoid replacement therapy instead of aldosterone due to the short half-life of aldosterone
Glucocorticoids e.g. hydrocortisone
Used for:
Glucocorticoid replacement therapy;
Immunosuppressive or anti-inflammatory effects for arthritis, asthma, or allergies;
Treatment of proliferative conditions e.g. leukaemia
Hydrocortisone (cortisol)
Acts via specific intracellular glucocorticoid receptors to influence gene expression
Used as an anti-inflammatory agent and immunosuppressant
Drug of choice for hormone replacement therapy
Standard dose =15-20mg per day in divided doses
Adverse effects: hyperglycaemia, osteoporosis, Cushing’s syndrome
Oral bioavailability = 60-80%
High protein binding ability
Hepatic metabolism with a half life of 1.5
Propylthiouracil (PTU)
Drug of choice to treat hyperthyroidism in first trimester
Used to treat hyperthyroidism including Graves’ disease
Inhibits thyroperoxidase and inhibits tetraiodothyronine deiodinase (converts T4 to T3)
Standard dose = 50-150mg/day
Oral bioavailabilty = 80-95%
70% protein binding
90& hepatic glucuronidation
Half-life of 2hrs
Renal excretion
Adverse effects: rashes and pruritus are common (rx with antihistamines); agranulocytosis; serious liver injury, liver failure and death
Carbimazole
Used to treat hyperthyroidism Prodrug therefore converted to methimazole which prevents peroxidase iodinating tyrosine residues on thyroglobulin, hence reducing the production of the thyroid hormones (T3 & T4) Standard dose: 5-15mg/day More than 90% oral bioavailability 85% protein bound Rapidly metabolised to methimazole Half-life of 6.4hrs 90% excreted in urine as metabolites Adverse effects: rashes and pruritus are common, neutropenia, agranulocytosis, teratogenic
Levothyroxine sodium
Used to treat thyroid deficiency (myxoedema, diffuse non-toxic goitre, hashimoto’s thyroiditis/lymphadenoid goitre, thryoid carcinoma)
Used to suppress TSH secretion in treatment of thyroid tumours
Given orally or by injection
Standard maintenance dose = 50-100 micrograms/day
100% bioavailability
More than 99% protein bound
Metabolised in liver by glucuronidation
Half-life of approx. 7days
20-40% excreted in urine
Adverse effects: at excessive doses palpitations, arrhythmias, diarrhoea, insomnia, tremor, weight loss, diarrhoea, vomiting, anginal pain, tachycardia
What drugs are associated with hyperprolactinaemia?
Antidepressants and antipsychotics (antidopaminergic action e.g. risperidone, trazodone, duloxetine)
Drugs for nausea and vertigo e.g. phenothiazines, metoclopramide, domperidone
Dopaminergic drugs
Cabergoline
Bromocriptine
Use of dopaminergic drugs
Treatment for prolactinoma, increases dopaminergic inhibition of prolactin to reduce prolactin production and shrink adenoma
Mechanism of action of Insulin
Affects all major metabolic pathways in liver, adipose tissue, and skeletal muscle
Net effect is to cause hypoglycemia and increase fuel storage in muscle, fat tissue and liver
Effect of Insulin on hepatocytes
decreases gluconeogenesis, glycogenolysis, ketogenesis, (increases glycogen synthesis)
Effect of insulin on muscle cells
increases GLUT-4 translocation to the membrane and hence increase glucose uptake, glucose oxidation, glycogen synthesis, amino acid uptake, protein synthesis
decreases glycogenolysis, amino acid release
Effect of insulin on adipocytes
increase glucose uptake, increase triglyceride synthesis; decrease FFA and glycerol release
Examples of sulfonylureas
Gliclazide
Glipizide
Glimepiride
Primary mechanism of action of sulfonylureas
Stimulates endogenous insulin release
Blocks ATP-sensitive K+ channel so potassium accumulates to depolarise beta cells. VGCCs open to allow calcium ions in and this mobilises vesicles to release endogenous insulin into the circulation
Secondary mechanism of action of sulphonylureas
Sensitise beta cells to glucose
Decrease lipolysis
Decrease clearance of insulin by the liver
Therapeutic uses of sulfonylureas
Useful in T2DM only - over 40yo, DM duration less than 10yrs, daily insulin (if taking) less than 40 units
Used in combo with other anti-diabetic drugs
Side effects of sulfonylureas
Hypoglycaemia
Side effects of Biguanides
Lactic acidosis Nausea Vomiting Anorexia VitB12/folate deficiency (chronic use)
Example of biguanides
Metformin
Mechanism of action of biguanides
Increase glucose uptake in muscle
Decrease glucose production by liver through AMPK which increases expression of nuclear transcription factor SHP and this inhibits the expression of hepatic gluconeogenic genes PEPCK and glucose-6-phosphatase
Properties of metformin
Orally active
Excreted unchanged in urine - half-life 1.3-4.5hrs
Often combined in a single pill
Carbergoline
Dopamine agonist
used to normalise IGF-1
What is used to normalise IGF-1 in acromegaly?
Carbergoline
Long-acting somatostatin analogue
Pegvisomant (GH receptor antagonist)